不応性白血病:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Refractory Leukemia Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Refractory Leukemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Refractory Leukemia to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Refractory Leukemia to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Refractory Leukemia 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Refractory Leukemia Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Sanofi 28
Clinical Trial Overview of Sanofi 28
Otsuka Pharmaceutical Co., Ltd. 29
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 29
Teva Pharmaceutical Industries Limited 30
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 30
Spectrum Pharmaceuticals, Inc. 31
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 31
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
Johnson & Johnson 33
Clinical Trial Overview of Johnson & Johnson 33
Bristol-Myers Squibb Company 34
Clinical Trial Overview of Bristol-Myers Squibb Company 34
BioCryst Pharmaceuticals, Inc. 35
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 35
AEterna Zentaris Inc. 36
Clinical Trial Overview of AEterna Zentaris Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
National Cancer Institute 37
Clinical Trial Overview of National Cancer Institute 37
The University of Texas M. D. Anderson Cancer Center 39
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 39
Sidney Kimmel Comprehensive Cancer Center 40
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 40
Fred Hutchinson Cancer Research Center 41
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 41
National Institutes of Health Clinical Center 42
Clinical Trial Overview of National Institutes of Health Clinical Center 42
Seattle Children’s Hospital, Research and Foundation 43
Clinical Trial Overview of Seattle Children’s Hospital, Research and Foundation 43
Children’s Oncology Group 44
Clinical Trial Overview of Children’s Oncology Group 44
Case Comprehensive Cancer Center 45
Clinical Trial Overview of Case Comprehensive Cancer Center 45
Five Key Clinical Profiles 46
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 82


【レポート販売概要】

■ タイトル:不応性白血病:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Refractory Leukemia Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2083CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。